KANE ROCKSthe deal with Animalcare Group in creating STEM is a big deal and that site should be fully functional soon but the wound care deal will be huge.
https://d1io3yog0oux5.cloudfront.net/_ba75517359a0ec7ac71075819872de0b/kanebiotech/db/447/3370/pdf/2736-KAN-Investor+Presentation+Dec+2020+.pdf Kane Wound Care and Surgical (KWCS) • Significant progress has been made towards creating Kane’s Wound Care Commercialization Vehicle at a valuation 4 to 5 times Kane’s current Market Cap. • Financing – over $7M in non-dilutive financing obtained and $6M available
Commercialization vehicle target Q2 2021 • $70M valuation estimated based on Strategic Partner investment • First commercial sale target Q1 2022
Advanced discussions with multiple potential partners – $7M equity investment – 9.9% equity stake in KWCS – Exclusive US rights to current and future Kane technology and products – Products to be purchased by strategic partner from KWCS and resold through existing sales network